{"organizations": [], "uuid": "22ce16bdebd73aba1b88f5910a0e96b58ecb2a5f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/10/globe-newswire-bioanalytical-systems-to-release-second-quarter-fiscal-2018aresults-on-tuesday-may-15-2018.html", "country": "US", "domain_rank": 767, "title": "Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.221, "site_type": "news", "published": "2018-05-10T16:33:00.000+03:00", "replies_count": 0, "uuid": "22ce16bdebd73aba1b88f5910a0e96b58ecb2a5f"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/10/globe-newswire-bioanalytical-systems-to-release-second-quarter-fiscal-2018aresults-on-tuesday-may-15-2018.html", "ord_in_thread": 0, "title": "Bioanalytical Systems to Release Second Quarter Fiscal 2018 Results on Tuesday, May 15, 2018", "locations": [], "entities": {"persons": [], "locations": [{"name": "lafayette", "sentiment": "none"}, {"name": "ind.", "sentiment": "none"}], "organizations": [{"name": "bioanalytical systems", "sentiment": "negative"}, {"name": "bioanalytical systems, inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WEST LAFAYETTE, Ind., Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it will report financial results for the second quarter and six months ended March 31, 2018, prior to the market opening on Tuesday, May 15, 2018.\nIf there are any questions after the press release is issued, please direct your comments to the investor relations contact noted in this release.\nAbout Bioanalytical Systems, Inc.\nBASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more information about BASi.\nThis release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.\nFOR MORE INFORMATION:\nCompany Contact:\nJill Blumhoff\nChief Financial Officer &\nVice President of Finance\nPhone: 765.497.8381\njblumhoff@BASinc.com\nSource:Bioanalytical Systems, Inc.", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/d8e767bd-af15-4e19-8997-41674dbdd33d", "https://www.globenewswire.com/Tracker?data=hDLIsBIxLxjG1ppXmEeARM0SOnxELN_OgnqmB_QmTffgkqjUezqALgZKdQ7c5GJJCAc02ZazIWvs13TqckZNcQ==", "https://www.globenewswire.com/Tracker?data=SMV01GahEFLkA2qgHSBGJqUupk5rZiiINWgNKKN3AHXnJ_SFQCZ3-sZQ5_3AnoxTpOlR4Jwe3ilJw-o5eQysZ3nJ4hKiebBcH5-KVBsaxpE="], "published": "2018-05-10T16:33:00.000+03:00", "crawled": "2018-05-10T17:08:43.033+03:00", "highlightTitle": ""}